Showing 1 – 20 of 39
Relevance | Newest | Oldest |
  • Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial

    Abstract Full Text
    is active quiz has multimedia
    JAMA. 2024; 331(17):1460-1470. 10.1001/jama.2024.4011

    This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.

  • Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia: The Norwegian Mother, Father and Child Cohort Study (MoBa)

    Abstract Full Text
    open access
    JAMA Psychiatry. 2022; 79(8):799-810. 10.1001/jamapsychiatry.2022.1728

    This cohort study explores whether pregnancy-related predisposing factors for offspring neurodevelopmental conditions are associated with maternal genetic liability for attention-deficit/hyperactivity disorder (ADHD), autism, and schizophrenia

  • Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement

    Abstract Full Text
    free access
    JAMA. 2021; 326(16):1614-1621. 10.1001/jama.2021.18236

    This Special Communication describes the development of the STROBE-MR Statement and includes the checklist of recommended items for inclusion in reports of mendelian randomization studies.

  • Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders: A Multivariable Mendelian Randomization Analysis

    Abstract Full Text
    open access
    JAMA Psychiatry. 2020; 78(2):151-160. 10.1001/jamapsychiatry.2020.3554

    This mendelian randomization analysis investigates the potential bidirectional associations between the genetic liability for prescription opioid and other nonopioid pain medications and both major depressive disorder and anxiety and stress-related disorders using genetically based methods

  • Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer

    Abstract Full Text
    free access
    JAMA. 2020; 323(7):646-655. 10.1001/jama.2020.0150

    This study uses mendelian randomization to estimate the associations between genetic variants related to reduced HMG-CoA reductase activity and epithelial ovarian cancer in the general population and in BRCA1/2 mutation carriers.

  • Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease

    Abstract Full Text
    free access has multimedia
    JAMA. 2019; 322(14):1381-1391. 10.1001/jama.2019.14120

    This genetic epidemiology study uses UK Biobank database data to estimate the association between genetic variants associated with lower low-density lipoprotein cholesterol (LDL-C), lower systolic blood pressure (SBP), or both and cardiovascular disease (CVD), defined as coronary death, nonfatal, myocardial infarction, or coronary revascularization.

  • Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures

    Abstract Full Text
    open access
    JAMA Psychiatry. 2019; 76(8):834-842. 10.1001/jamapsychiatry.2019.0774

    This population-based cohort study assesses whether maternal polygenic risk scores for neurodevelopmental disorders are associated with early-life exposures previously linked to the disorders in women with available genotype data.

  • Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2019; 2(3):e190305. 10.1001/jamanetworkopen.2019.0305

    This population-based cohort study uses mendelian randomization to examine the association of body mass index (BMI) and alcohol consumption with levels of liver injury biomarkers and incident liver disease in adults in Denmark.

  • Adiposity and Cardiometabolic Outcomes: What Can Meta-analyses of Mendelian Randomization Studies Contribute?

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2018; 1(7):e183778. 10.1001/jamanetworkopen.2018.3778
  • Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial

    Abstract Full Text
    free access
    JAMA. 2018; 319(9):883-895. 10.1001/jama.2018.0154

    This cluster randomized trial evaluates the effect of a single prostate-specific antigen (PSA) screening test on 10-year prostate cancer–specific mortality among men aged 50 to 69 years treated at UK primary care practices.

  • Biased Estimates in Mendelian Randomization Studies Conducted in Unrepresentative Samples

    Abstract Full Text
    JAMA Cardiol. 2018; 3(2):181-181. 10.1001/jamacardio.2017.4279
  • Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study

    Abstract Full Text
    open access
    JAMA Psychiatry. 2017; 74(12):1226-1233. 10.1001/jamapsychiatry.2017.3191

    This study uses mendelian randomization of candidate gene or genome-wide association studies to evaluate the association between inflammatory biomarkers and the risk of schizophrenia.

  • Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

    Abstract Full Text
    free access
    JAMA. 2017; 318(10):947-956. 10.1001/jama.2017.11467

    This mendelian randomization analysis of individual-participant data estimated the association between changes in levels of low-density lipoprotein cholesterol (and other lipoproteins) and risk of cardiovascular events due to CETP variants, alone and in combination with HMGCR variants.

  • Difficulties in Testing the Instrument Strength Independent of Direct Effect Assumption in Mendelian Randomization

    Abstract Full Text
    JAMA Cardiol. 2017; 2(8):929-930. 10.1001/jamacardio.2017.1572
  • Acetaminophen in Pregnancy and Adverse Childhood Neurodevelopment—Reply

    Abstract Full Text
    JAMA Pediatr. 2017; 171(4):396-397. 10.1001/jamapediatrics.2016.5040
  • When Will Mendelian Randomization Become Relevant for Clinical Practice and Public Health?

    Abstract Full Text
    JAMA. 2017; 317(6):589-591. 10.1001/jama.2016.21189
  • Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population

    Abstract Full Text
    free access
    JAMA Psychiatry. 2016; 73(12):1285-1292. 10.1001/jamapsychiatry.2016.2817

    This population-based cohort study examines whether genetic risk for attention-deficit/hyperactivity disorder is associated with symptom trajectories across childhood and adolescence, and whether higher genetic liability for attention-deficit/hyperactivity disorder is correlated with childhood multimorbidity.

  • Association of a Genetic Risk Score With Body Mass Index

    Abstract Full Text
    JAMA. 2016; 316(17):1825-1826. 10.1001/jama.2016.14933
  • Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding

    Abstract Full Text
    free access
    JAMA Pediatr. 2016; 170(10):964-970. 10.1001/jamapediatrics.2016.1775

    This cohort study compares estimates of association between parental acetaminophen use and child conduct disorders for maternal prenatal, maternal postnatal, and partner use to understand the degree to which unmeasured behavioral variables might account for observed associations.

  • Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight

    Abstract Full Text
    free access
    JAMA. 2016; 315(11):1129-1140. 10.1001/jama.2016.1975

    This genetic epidemiology study uses mendelian randomization to investigate associations between maternal body mass index and glucose and lipid levels and offspring birth weight between 1929 and 2013.